0001019056-18-000463.txt : 20180321 0001019056-18-000463.hdr.sgml : 20180321 20180321115714 ACCESSION NUMBER: 0001019056-18-000463 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180319 FILED AS OF DATE: 20180321 DATE AS OF CHANGE: 20180321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: White Marvin L CENTRAL INDEX KEY: 0001493324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37746 FILM NUMBER: 18703898 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aptevo Therapeutics Inc. CENTRAL INDEX KEY: 0001671584 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811567056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-838-0500 MAIL ADDRESS: STREET 1: 2401 4TH AVE. STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 white_4.xml OWNERSHIP DOCUMENT X0306 4 2018-03-19 0 0001671584 Aptevo Therapeutics Inc. APVO 0001493324 White Marvin L 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121 1 1 0 0 President and CEO Common Stock 2018-03-19 4 S 0 100000 2.93 A 166332 D The selling price of $2.93 is reflective of the weighted average sale price. The prices for the transactions reported on this line range from $2.865 to $3.020, inclusive. Mr. White undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. /s/ Benjamin J. Stein, attorney-in-fact 2018-03-21